NZ248627A - Pharmaceutical adsorbate composition: pyridine derivative as the active agent together with silica, an inert auxiliary and optionally starch - Google Patents
Pharmaceutical adsorbate composition: pyridine derivative as the active agent together with silica, an inert auxiliary and optionally starchInfo
- Publication number
- NZ248627A NZ248627A NZ248627A NZ24862793A NZ248627A NZ 248627 A NZ248627 A NZ 248627A NZ 248627 A NZ248627 A NZ 248627A NZ 24862793 A NZ24862793 A NZ 24862793A NZ 248627 A NZ248627 A NZ 248627A
- Authority
- NZ
- New Zealand
- Prior art keywords
- pharmaceutical
- silica
- active agent
- pyridine derivative
- agent together
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
Landscapes
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4230371 | 1992-09-11 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ248627A true NZ248627A (en) | 1995-01-27 |
Family
ID=6467712
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ248627A NZ248627A (en) | 1992-09-11 | 1993-09-09 | Pharmaceutical adsorbate composition: pyridine derivative as the active agent together with silica, an inert auxiliary and optionally starch |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP0587137A1 (show.php) |
| JP (1) | JPH06192093A (show.php) |
| KR (1) | KR940006583A (show.php) |
| AU (1) | AU663000B2 (show.php) |
| CA (1) | CA2105913A1 (show.php) |
| FI (1) | FI933954L (show.php) |
| HU (1) | HUT67577A (show.php) |
| IL (1) | IL106953A0 (show.php) |
| MX (1) | MX9305578A (show.php) |
| NO (1) | NO933237L (show.php) |
| NZ (1) | NZ248627A (show.php) |
| TW (1) | TW222585B (show.php) |
| ZA (1) | ZA936695B (show.php) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0701434B1 (en) * | 1993-06-04 | 2002-08-07 | Warner-Lambert Company | Preparations containing silicon dioxide to improve the taste thereof |
| US5626878A (en) * | 1995-01-10 | 1997-05-06 | Warner Lambert Company | Reduction of electrostatic forces between magnesium trisilicate adsorbates |
| BR9916361A (pt) * | 1998-12-18 | 2002-11-05 | Abbott Lab | Forma de dosagem de tabletes de liberação controlada, formulação de tablete de liberação controlada, composição granular para prensagem em uma forma de dosagem de tablete de liberação controlada, e, métodos para preparar uma composição granular, para preparar uma forma de dosagem de tabletes de liberação controlada de divalproex sódio e para tratar epilepsia |
| AU2005256322C1 (en) * | 2004-06-28 | 2011-07-07 | Veloxis Pharmaceuticals, Inc. | Porous tablets as carriers for liquid formulations |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2879161A (en) * | 1956-05-14 | 1959-03-24 | American Cyanamid Co | Stable dry powder compositions containing choline chloride and methods of preparing same |
| DE3409063A1 (de) * | 1984-03-13 | 1985-09-19 | Basf Ag, 6700 Ludwigshafen | Verfahren zur herstellung von fliessfaehigen cholinchlorid-kieselsaeure-pulvern |
| DE3924093A1 (de) * | 1989-07-20 | 1991-02-07 | Hoechst Ag | N,n'-bis(alkoxy-alkyl)-pyridin-2,4-dicarbonsaeurediamide, verfahren zu deren herstellung sowie deren verwendung |
| DE4020570A1 (de) * | 1990-06-28 | 1992-01-02 | Hoechst Ag | 2,4- und 2,5-substituierte pyridin-n-oxide, verfahren zu deren herstellung sowie deren verwendung |
| GB9025251D0 (en) * | 1990-11-20 | 1991-01-02 | Solomon Montague C | Nifedipine dosage forms |
-
1993
- 1993-03-02 TW TW082101487A patent/TW222585B/zh active
- 1993-09-08 EP EP93114413A patent/EP0587137A1/de not_active Withdrawn
- 1993-09-09 IL IL106953A patent/IL106953A0/xx unknown
- 1993-09-09 FI FI933954A patent/FI933954L/fi not_active Application Discontinuation
- 1993-09-09 HU HU9302555A patent/HUT67577A/hu unknown
- 1993-09-09 KR KR1019930018067A patent/KR940006583A/ko not_active Withdrawn
- 1993-09-09 NZ NZ248627A patent/NZ248627A/xx unknown
- 1993-09-10 AU AU46262/93A patent/AU663000B2/en not_active Ceased
- 1993-09-10 MX MX9305578A patent/MX9305578A/es not_active Application Discontinuation
- 1993-09-10 NO NO933237A patent/NO933237L/no unknown
- 1993-09-10 ZA ZA936695A patent/ZA936695B/xx unknown
- 1993-09-10 JP JP5225707A patent/JPH06192093A/ja active Pending
- 1993-09-10 CA CA002105913A patent/CA2105913A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| TW222585B (show.php) | 1994-04-21 |
| AU663000B2 (en) | 1995-09-21 |
| JPH06192093A (ja) | 1994-07-12 |
| IL106953A0 (en) | 1993-12-28 |
| KR940006583A (ko) | 1994-04-25 |
| EP0587137A1 (de) | 1994-03-16 |
| AU4626293A (en) | 1994-03-17 |
| NO933237D0 (no) | 1993-09-10 |
| CA2105913A1 (en) | 1994-03-12 |
| ZA936695B (en) | 1994-04-05 |
| FI933954A7 (fi) | 1994-03-12 |
| HUT67577A (en) | 1995-04-28 |
| FI933954A0 (fi) | 1993-09-09 |
| HU9302555D0 (en) | 1993-11-29 |
| MX9305578A (es) | 1994-03-31 |
| NO933237L (no) | 1994-03-14 |
| FI933954L (fi) | 1994-03-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP9601566A3 (en) | Therapeutic tetrahydro-isoquinolin derivatives, their intermediates and pharmaceutical compositions containing the active component | |
| AU3296893A (en) | Benzimidazolyl derivatives | |
| EP0586537A4 (en) | Substituted n-carboxyalkylpeptidyl derivatives as antidegenerative active agents | |
| AU7020787A (en) | Azacycloalkane derivatives, absorption promoters containing the derivatives as the effective ingredient and external preparations containing the absorption promoters | |
| AU4123793A (en) | Benzimidazole derivatives | |
| HU9600427D0 (en) | Benzazepine derivative, pharmaceutical composition containing the same, and intermediate for the same | |
| AU7184994A (en) | Imidazole derivatives as therapeutic agents | |
| AU6309698A (en) | Drugs containing aminopyridine derivatives as the active ingredient | |
| AU3352693A (en) | Pyridone derivatives, their preparation and use as medicines | |
| AU3352593A (en) | Pyridine derivatives, their preparation and use as medicines | |
| AU5156893A (en) | Prostaglandine derivative | |
| AU3049192A (en) | An oxazoline derivative, its production and its use | |
| AU3651795A (en) | Substituted pyrazolyl-pyrazole derivatives, processes for their preparation and their use as agents with herbicidal action | |
| IL104471A0 (en) | Imidazole derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same | |
| NZ248627A (en) | Pharmaceutical adsorbate composition: pyridine derivative as the active agent together with silica, an inert auxiliary and optionally starch | |
| GB9310075D0 (en) | New mercapto-amide derivatives,processes for the preparation thereof and pharmaceutical composition comprising the same | |
| AU3347493A (en) | Pharmaceutically active substituted benzimidazole derivatives | |
| GB9216962D0 (en) | Therapeutically active naphthalenesulfonic-pyrrolecarboxamido derivatives | |
| AU2361295A (en) | N-carboxyalkyl derivatives as antidegenerative active agents | |
| AU588409B2 (en) | Pyridine derivatives, processes for the preparation thereof, agents containing same, and the use thereof as pesticides | |
| AU3574293A (en) | Novel azole derivative, production thereof and pharmaceutical composition | |
| AU3533095A (en) | Arylthiadiazole derivative and antiviral agent containing the same | |
| AU4132693A (en) | Substituted 1,2,4-triazine-3,5-dione derivative and anticoccidial drug composition containing the same as active component | |
| AU5251493A (en) | Oxalyl hydrazide-hydroxamic acid derivatives, their preparation and their use as fungicides | |
| HU00525A9 (en) | Indolizine derivatives, with pharmaceutical activity |